Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Biotricity, Inc. - Common Stock (NQ:BTCY)

0.4631 UNCHANGED
Last Price Updated: 4:00 PM EDT, Aug 2, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Biotricity, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
Biotricity to Report Fourth Quarter Fiscal 2021 and Financial Results on June 15, 2021
REDWOOD CITY, CA / ACCESSWIRE / June 9, 2021 / Biotricity, Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, today announced that it will release its financial results... 
From Biotricity, Inc.
Via AccessWire
Topics Regulatory Compliance
Exposures Legal Regulatory
Lasting Impact of Covid: Fewer Doctor's Office Visits Thanks to At-Home Diagnostics
While treatment has long been viewed as the central role of our healthcare system, the COVID-19 pandemic brought diagnostics to center stage. Early and accurate detection was... 
Via Benzinga
Exposures COVID-19
Biotricity to Present at 2021 LD Micro Invitational XI
REDWOOD CITY, CA / ACCESSWIRE / June 1, 2021 / Biotricity Inc. (OTCQB:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, announced today that its... 
From Biotricity, Inc.
Via AccessWire
Biotricity Announces 2021 Uplisting Strategy to Major Exchange
REDWOOD CITY, CA / ACCESSWIRE / May 25, 2021 / Biotricity, Inc. (OTCQB:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, is pleased to announce... 
From Biotricity, Inc.
Via AccessWire
Topics Regulatory Compliance
Exposures Legal Regulatory
Biotricity to Present its Disruptive Medical Technologies at the Benzinga Global Small Cap Conference on May 14
Presentation to focus on flagship Bioflux® product for the multi-billion cardiac monitoring and diagnostic market REDWOOD CITY, CA / ACCESSWIRE / May 14, 2021 /Biotricity, Inc. (OTCQB:BTCY)... 
From Biotricity, Inc.
Via AccessWire
Topics Regulatory Compliance
Exposures Legal Regulatory
Maxim Group Is Bullish About Biotricity Generating Over 100% Revenue Growth
Biotricity Inc (OTC: BTCY) has a multi-billion dollar target addressable market, which should expand as an ecosystem is created for solutions to chronic conditions, according to... 
Via Benzinga
Biotricity Selected as Finalist in Fast Company's 2021 World Changing Ideas Awards
REDWOOD CITY, CA / ACCESSWIRE / May 4, 2021 / Biotricity, Inc. (OTCQB:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, is pleased to announce that... 
From Biotricity, Inc.
Via AccessWire
Topics Regulatory Compliance
Exposures Legal Regulatory
Remote Monitoring Telemedicine Company Sees Spiked Growth Of Products And Technology
The following article is sponsored by Biotricity Inc. The information contained in this article in no way represents investment advice or opinion on the part of Benzinga or its... 
Via Benzinga
Biotricity to Report Record Revenue Results for Fiscal 2021
Unaudited Financial Results Include Revenue Growth of 133% REDWOOD CITY, CA / ACCESSWIRE / April 14, 2021 / Biotricity, Inc. (OTCQB:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and... 
From Biotricity, Inc.
Via AccessWire
Topics Regulatory Compliance
Exposures Legal Regulatory
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback